MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Research Suggests Statins Linked to Anti-Cancer Benefits

Jan 7, 2020 | Cancer, Cholesterol, Prescription drugs, Statins, Wellness

According to American Heart Association, about 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease – and new research suggests that they might also be getting an added anti-cancer benefit. The study found that...

Heart Medication Therapy Can Be Just as Effective as Surgery

Nov 27, 2019 | Heart medications, Prescription drugs

At the annual meeting of the American Heart Association, researchers reported that patients who received drug therapy alone did not experience more heart attacks or die more often than those who also received bypass surgery or stents – further evidence that a...

MedBen Rx Solutions for Prescription Pricing

Nov 15, 2019 | MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx Spending, Savings

Prescription drug pricing is regularly a hot topic in the news and from political candidates. While lawmakers seek to address consumer concerns, MedBen already has innovative pharmacy solutions in place that offer employers price transparency and cost savings. With...

MedBen Rx Advocate Eliminates the “Spread”

Oct 18, 2019 | MedBen Rx, MedBen Rx Advocate, Pharmacies, Pharmacy Benefits Manager (PBM), Spread Pricing, Transparency

A key to reducing pharmacy plan costs is to eliminate the use of spread pricing – the difference between what pharmacy benefit managers (PBMs) charge employer plans for drugs and what the actual pharmacy pays for them. Often, this “spread” can be substantial, as PBMs...

MedBen Ahead of Pharmacy Costs

Sep 7, 2019 | MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending

An article released by Health Payer Intelligence focuses on the concern that employers have about the rising cost of health care. More specifically, the article states that with 85 percent of employers surveyed, pharmacy pricing was their predominant concern going...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.